Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa : a systematic review and meta-analysis

Tools
- Tools
+ Tools

Adetokunboh, Olatunji O., Awotiwon, Ajibola, Ndwandwe, Duduzile, Uthman, Olalekan A. and Wiysonge, Charles S. (2019) The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa : a systematic review and meta-analysis. Human Vaccines & Immunotherapeutics, 15 (11). pp. 2590-2605. doi:10.1080/21645515.2019.1599676 ISSN 2164-5515.

[img]
Preview
PDF
WRAP-burden-vaccine-preventable-diseases-HIV-Africa-meta-analysis-Uthman-2019.pdf - Accepted Version - Requires a PDF viewer.

Download (3826Kb) | Preview
Official URL: https://doi.org/10.1080/21645515.2019.1599676

Request Changes to record.

Abstract

There are knowledge gaps regarding evidence-based research on the burden of vaccine-preventable diseases among human immunodeficiency virus (HIV)-infected and HIV-exposed children aged <18 years in sub-Saharan Africa. It is therefore essential to determine the trend and burden of vaccine-preventable diseases. We completed a systematic review and meta-analysis to identify the incidence, prevalence and case-fatality rates (CFR) attributed to various vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa. The trends in the prevalence of vaccine-preventable diseases among HIV-infected and HIV-exposed children were also determined. Nine studies on tuberculosis (TB) were pooled to give an overall incidence rate estimate of 60 (95% confidence interval [CI] 30-70) per 1,000 child-years. The incidence of pneumococcal infections varied between 109-1509 per 100,000 while pertussis was between 2.9 and 3.7 per 1000 child-year. Twenty-two TB prevalence studies reported an estimated prevalence of 16%. Fifteen prevalence studies on hepatitis B infection were pooled together with an estimated prevalence of 5%. The pooled prevalence for pneumococcal infections was 2% while rotavirus diarrhoea reported a prevalence of 13%. Twenty-nine studies on TB were pooled to give an overall CFR estimate of 17% while pneumococcal infections in HIV-infected and exposed children were pooled together with a resultant rate of 15%. Some of the vaccine-preventable diseases still have high incidences, prevalence and CFR among HIV-infected and HIV-exposed children. There is also a dearth of research data on the burden of several vaccine-preventable diseases among HIV-infected and exposed children and a need for more studies in this area.

Item Type: Journal Article
Subjects: R Medicine > RJ Pediatrics > RJ101 Child Health. Child health services
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
SWORD Depositor: Library Publications Router
Library of Congress Subject Headings (LCSH): HIV-positive children -- Treatment -- South Africa, AIDS vaccines -- South Africa
Journal or Publication Title: Human Vaccines & Immunotherapeutics
Publisher: Landes Bioscience
ISSN: 2164-5515
Official Date: 22 May 2019
Dates:
DateEvent
22 May 2019Published
4 April 2019Available
18 March 2019Accepted
Volume: 15
Number: 11
Page Range: pp. 2590-2605
DOI: 10.1080/21645515.2019.1599676
Status: Peer Reviewed
Publication Status: Published
Reuse Statement (publisher, data, author rights): ** From PubMed via Jisc Publications Router
Access rights to Published version: Restricted or Subscription Access
Date of first compliant deposit: 5 June 2019
Date of first compliant Open Access: 4 April 2020
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
106035National Research Foundation (South Africa)http://viaf.org/viaf/137694659
108571National Research Foundation (South Africa)http://viaf.org/viaf/137694659
UNSPECIFIEDSouth African Medical Research Councilhttp://dx.doi.org/10.13039/501100001322

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us